Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing …

TN Demidova-Rice, MR Hamblin… - Advances in skin & …, 2012 - journals.lww.com
This is the second of 2 articles that discuss the biology and pathophysiology of wound
healing, reviewing the role that growth factors play in this process and describing the current …

Affinity‐based drug delivery

NX Wang, HA von Recum - Macromolecular bioscience, 2011 - Wiley Online Library
Affinity‐based drug delivery systems utilize interactions between the therapeutic drug and
the delivery system to manipulate drug loading and to control drug release. In this paper …

Design of 3D polycaprolactone/ε-polylysine-modified chitosan fibrous scaffolds with incorporation of bioactive factors for accelerating wound healing

P Li, L Ruan, G Jiang, Y Sun, R Wang, X Gao… - Acta Biomaterialia, 2022 - Elsevier
Electrospun nanofibrous scaffolds show great application potentials for wound healing
owing to their effective simulation of extracellular matrix (ECM). Three-dimensional (3D) …

From natural bone grafts to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges

B Baroli - Journal of pharmaceutical sciences, 2009 - Elsevier
Tissue engineering is an emerging multidisciplinary field of investigation focused on the
regeneration of diseased or injured tissues through the delivery of appropriate molecular …

The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration

J Lee, JJ Yoo, A Atala, SJ Lee - Biomaterials, 2012 - Elsevier
Heparin-conjugated electrospun poly (ε-caprolactone)(PCL)/gelatin scaffolds were
developed to provide controlled release of platelet-derived growth factor-BB (PDGF-BB) and …

Heparin-functionalized chitosan–alginate scaffolds for controlled release of growth factor

YC Ho, FL Mi, HW Sung, PL Kuo - International journal of pharmaceutics, 2009 - Elsevier
Controlled long-term release of basic fibroblast growth factor (bFGF) has shown a combined
effect on the stimulation of regenerating a number of tissues including cartilage, nerve, skin …

Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair

S Liu, H Zhang, X Zhang, W Lu, X Huang… - … Engineering Part A, 2011 - liebertpub.com
Slow vascularization rate is considered one of the main drawbacks of scaffolds used in
wound healing. Several efforts, including cellular and acellular technologies, have been …

Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds

Q Tan, H Tang, J Hu, Y Hu, X Zhou… - International journal of …, 2011 - Taylor & Francis
Regeneration deficiency is one of the main obstacles limiting the effectiveness of tissue-
engineered scaffolds. To develop scaffolds that are capable of accelerating regeneration …

Proteolysis: a biological process adapted in drug delivery, therapy, and imaging

B Law, CH Tung - Bioconjugate chemistry, 2009 - ACS Publications
In many diseases, protease expressions are found deregulated when compared with them
at the healthy states. The unique ability to hydrolyze protein amide bonds has made those …

The effect of cross-linking of collagen matrices on their angiogenic capability

C Yao, M Markowicz, N Pallua, EM Noah, G Steffens - Biomaterials, 2008 - Elsevier
The poor vascularization rate of matrices following cell invasion is considered to be one of
the main shortcomings of scaffolds used in tissue engineering. In the past decade much …